United States · FDA National Drug Code directory
Linezolid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57664-682_d717dddc-2ff8-4953-8efc-c86ad9342f7d
- Product NDC
- 57664-682
- Form
- INJECTION, SOLUTION
- Composition / generic term
- linezolid
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170201
- Source listing expiry
- 20271231
Source-listed ingredients
- LINEZOLID — 200 mg/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BAG (57664-682-30) · 57664-682-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →